Biotechnology Industry · SOC 2 Type I & Type II · AICPA TSC

SOC 2 Certification for Biotechnology
— Type I in 2 Months, Type II in 4

A SOC 2 consulting partner built for Genomics & sequencing, Research & lab platforms and Drug & therapeutic R&D. We get you SOC 2 Certification for Biotechnology end-to-end — from readiness assessment to a clean CPA-attested Type I and Type II report.

As certified partners of Drata, Sprinto and Secureframe, we operationalise every Trust Services Criterion inside the tools engineering already runs — AWS, Azure, GCP, GitHub, Okta and Jira — so evidence is collected automatically across the observation window.

Months to SOC 2 Type I

Global Enterprises Served

First-attempt audit pass rate

Drata . Sprinto . Secureframe partner

Get Your Free SOC 2 Roadmap See the 6-Stage Process

Free Roadmap

24h Response

Request a Free Biotechnology SOC 2 Readiness Roadmap

200+ Biotechnology clients 100% first pass

SSL Encrypted No spam ever 100% Confidential

Why It Matters For Biotechnology

Why Biotechnology Companies Can No Longer Skip SOC 2

Biotech firms hold genomic, research and clinical data that is both sensitive and irreplaceable IP. Pharma partners, funders and enterprise collaborators require a SOC 2 report before they share data or systems. Without it, research partnerships and licensing deals stall.

SOC 2 Certification for Biotechnology is the AICPA-recognised attestation that an independent CPA firm has examined your controls against the five Trust Services Criteria — Security, Availability, Processing Integrity, Confidentiality and Privacy. A Type I report proves your controls are well-designed; a Type II report proves they actually operated effectively across an observation window of about 4 months. To an enterprise buyer, that report is the difference between “approved vendor” and “rejected”.

We map criteria to research platforms — genomic and lab-data protection, ELN/LIMS access controls, IP segregation, and partner integrations. SOC 2 evidence is automated so pharma partners and funders can share data and systems with confidence.

The Cost Of Inaction

The Real Business Cost of Skipping SOC 2 Certification for Biotechnology

For B2B Biotechnology companies, no SOC 2 report is a measurable drag on revenue, sales velocity and buyer trust.

Lost enterprise deals

Pharma partners, funders and collaborators require a SOC 2 report before sharing data or systems.

Breach exposure

Genomic and research data is irreplaceable IP; a breach is both costly and unrecoverable.

)

Slower sales cycles

Without SOC 2, research partnerships and licensing deals stall in security review.

⚠

Regulatory & insurance pressure

HIPAA, 21 CFR Part 11 and GDPR increasingly expect audited controls.

The ISpectra Method

Our 6-Stage SOC 2 Certification for Biotechnology Process

Click through the timeline — or hit play and watch the sprint run. Most Biotechnology clients reach SOC 2 Type I in about 2 months, then SOC 2 Type II in about 4 months.

Engineered, Not Templated

The 5 Trust Services Criteria, mapped to your Biotechnology stack

How we operationalise each Trust Services Criterion — in the tools your engineers already run, with evidence captured automatically in Drata, Sprinto or Secureframe.

Security · Mandatory

Access control, change management, risk assessment and continuous monitoring across your ELN/LIMS, genomic pipelines and research data.

AWS IAMOkta SSO + MFA24/7 logging

Availability · Optional

Uptime, resilience and tested recovery so the services delivering your genomic and research data stay available as committed.

Multi-AZSLA monitoringTested backups / DR

Processing Integrity · Optional

Complete, valid, accurate and timely processing of genomic and research data.

Input validationJob monitoringQA gates

Confidentiality · Optional

Encryption, classification and least-privilege protection for genomic and research data.

KMS / TLSData classificationTenant isolation

Privacy · Optional

Lawful collection, use, retention and disposal of the personal data across your ELN/LIMS, genomic pipelines and research data.

Notice & consentDSAR handlingGDPR / CCPA

Evidence, collected automatically

Each criterion maps to controls captured continuously — no screenshot scramble before the CPA examination.

DrataSprintoSecureframe

Sub-Verticals We Serve

Biotechnology Sub-Verticals We Certify

Tailored SOC 2 Certification for Biotechnology engagements designed around the data flows and buyer expectations of every Biotechnology business model.

Genomics & sequencing

Genomic, sequencing and bioinformatics platforms.

Research & lab platforms

ELN, LIMS and lab-data-management systems.

Drug & therapeutic R&D

Discovery and computational-biology platforms.

Clinical & translational

Translational-research and biobank data platforms.

Synthetic & industrial bio

Synthetic-biology and bioprocess platforms.

Diagnostics & devices

Diagnostic and connected-device data platforms.

One Programme, Many Audits

Frameworks Biotechnology teams run alongside SOC 2

SOC 2 reuses most of the same controls as the standards your Biotechnology buyers, regulators and auditors already expect — so one control set satisfies many. We map the overlap and reuse up to 80% of your evidence.

HIPAA

For clinical and patient data.

21 CFR Part 11

Electronic records where applicable.

ISO 27001

ISMS certification overlapping SOC 2.

GDPR

For EU research-participant data.

GxP

Good-practice controls for regulated work.

SOC 2 Confidentiality

Protecting research IP.

Risk, Under Control

The Biotechnology security risks SOC 2 puts under control

The Trust Services Criteria map directly to the threats that matter most in Biotechnology — here is what your SOC 2 programme is built to contain.

Genomic-data exposure

Leakage of sequence and participant data.

Research-IP theft

Loss of proprietary methods and results.

Lab-system compromise

ELN/LIMS access abused or breached.

Collaborator risk

Partner weaknesses exposing shared research.

The Decision Matters

Without a report, or SOC 2 attested — side by side

The reality for a B2B Biotechnology company, both views at a glance.

Without SOC 2

The real cost of doing nothing

×Pharma partners and funders screen you out before the first call without a report
×Every Biotechnology security review restarts from a blank questionnaire
×Higher exposure for genomic and research data with no attested controls
×Tougher cyber-insurance terms & longer HIPAA / 21 CFR Part 11 audits
×One failed review erodes hard-won Biotechnology trust

With SOC 2 — attested

The upside of getting attested

✓Clear pharma partners and funders procurement the day your report is issued
✓30–45% faster Biotechnology sales cycles with a pre-built CAIQ / SIG
✓Stronger cyber-insurance terms with attested controls over genomic and research data
✓One control set reused across HIPAA, 21 CFR Part 11 and ISO 27001
✓Engineering hours returned through automated evidence

Which report?

SOC 2 Type I vs Type II

SOC 2 Type I

Point-in-time

Attests controls are suitably designed on a specific date
~2 months from kickoff
Fastest way to answer a buyer asking for SOC 2 now

SOC 2 Type II

Over a period

Attests controls operated effectively over a ~4-month window
The report most enterprise buyers ultimately require
Continuous evidence, renewed annually on a rolling basis

Illustrative ROI

What’s a stuck deal worth?

Average contract value (ACV)

$60,000

Enterprise deals blocked on “no SOC 2” per year

Pipeline you could unlock

$480,000

Illustrative estimate only — based on the numbers you enter.

Why ISpectra

Why Leading Biotechnology Companies Choose ISpectra for SOC 2

A specialist consultancy delivering SOC 2 Certification for Biotechnology firms across the US, India, the EU and the Middle East — with a 100% first-attempt audit pass record.

2 mo

To Type I report

Fastest fixed-fee delivery in the industry — kickoff to a clean CPA-attested Type I report.

3×

Compliance automation partner

Certified partner of Drata, Sprinto and Secureframe — lower licensing and faster evidence.

100%

First-attempt audit pass

Zero failed examinations across 200+ engagements — every issue caught in our internal audit.

Get a fixed-fee, written quote for your SOC 2 programme within 48 hours of your readiness call.

Get a Fixed-Fee Quote WhatsApp Us

Trusted by 200+ Global Enterprise Clients

What Enterprise Clients Say

Real B2B Results from
Real Partnerships

“ISpectra Technologies brought deep expertise in cybersecurity and DevSecOps to our projects, playing a crucial role in our EDR Tool implementations and SOC 2 compliance. Their solutions were tailored to our business and their proactive approach improved both our agility and security posture. ISpectra felt more like an extension of our team than an external vendor.”

Irina Zakharchenko

Chief Operations and People Officer

DocsDNA

SOC 2 Certified

FAQ — SOC 2 for Biotechnology

Frequently Asked SOC 2 Questions

Everything Biotechnology founders, CTOs and security leads ask before starting SOC 2.

SOC 2 is an AICPA attestation in which a licensed CPA firm examines your controls against the five Trust Services Criteria. For Biotechnology, MSPs and cloud providers it is the universally accepted proof that customer data is handled securely — and is the default qualifying filter in most North American enterprise vendor reviews.

Type I attests that your controls are suitably designed at a single point in time. Type II attests that those controls operated effectively across an observation window of about 4 months. Most enterprise buyers ultimately require Type II, so we get you Type I in about 2 months then support the observation period.

Most Biotechnology companies reach Type I in about 2 months with our fixed-fee model, then Type II in about 4 months after the observation window. Larger multi-product Biotechnology groups running ISO 27001 in parallel may take a little longer.

Security (the Common Criteria) is mandatory. Most Biotechnology platforms add Availability and Confidentiality; Processing Integrity and Privacy are scoped in for payments, analytics and PII-heavy products. We help you scope the right criteria to match buyer demand without over-auditing.

A SOC 2 report covers a defined period and is generally refreshed every 12 months. Buyers typically expect a report no older than a year, so Biotechnology companies run a rolling annual Type II. We support the full lifecycle, including bridge letters between report dates.

Yes — and most Biotechnology clients do. SOC 2 controls overlap heavily with ISO 27001 Annex A and HIPAA safeguards. Running them together reuses up to 80% of the same evidence and saves around 40% versus sequential audits.

B2B Biotechnology platforms, MSPs and MSSPs, cloud service providers, software engineering firms, IT consulting and staffing groups, and data/AI platforms selling into US enterprise, healthcare or finance — where a SOC 2 report is a routine prerequisite to close.

A licensed independent CPA firm issues the SOC 2 attestation report — not ISpectra. We prepare your environment, run the internal audit and coordinate the CPA examination end-to-end, so your team stays focused on shipping product.

ISpectra handles the heavy lifting — readiness and risk assessment, 30+ policies, control rollout, internal audit, management review and CPA coordination. Your team provides inputs, approves deliverables and runs day-to-day operations — typically under 10% of one FTE through the sprint.

Free B2B Security Assessment

Ready to Start Your
SOC 2 Certification for Biotechnology?

What you receive

Written readiness-gap report
Recommended Trust Services Criteria scope
Fixed-fee quote in 48 hours
Type I → Type II roadmap
Compliance-automation platform pick
1-hour call with a SOC 2 Lead

No obligation · Results in 48 hours · 100% confidential

Schedule a Call

Pick a time that works for you

Enable JavaScript to view the Calendly scheduler.

Open Calendly

Request Assessment

Our team responds within 24 hours

No spam. No obligations. We'll respond within 24 hours.

Encrypted & 100% confidential